US$ 27.22
gip/glp-1 drugs GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GLP-1/GIP Receptor Agonists and Diabetic
Description
doi: 10.1111/obr.13929

M., Ryan D

Changes in this receptor are linked to some types of type 2 diabetes
These findings provide a relevant basis for the prevention of AD

Edholm, T
Consistent with the conclusion that GLP-1 suppression of glucagon secretion does not fully depend on somatostatin, GLP-1 effects on glucagon secretion can be mimicked by forskolin-induced changes in cAMP